
Videos







Rapidly Progressing Acute Myeloid Leukemia













Chronic Lymphocytic Leukemia

Graft versus Host Disease

Shlomo Koyfman, MD, discusses registry data on thyroid cancer and how data from the registry can improve practice for oncologists.

Heather H. Cheng, MD, PhD, discusses the role of genetic testing in prostate cancer as it continues to evolve in this space. This year, the 2019 NCCN guidelines focused more on genetic testing in select patients with prostate cancer.

Bianca D. Santomasso, MD, PhD, discusses the challenges that exist for the treatment of patients with diffuse large B-cell lymphoma with CAR T-cell therapy.






Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ctDNA Assay Offers Prognostic Insights for Immunotherapy-Treated Solid Tumors
2
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
ctDNA Refines Risk in Neoadjuvant-Resistant Breast Cancer
5

